Proper Joint Care Cardiovascular health Immunity Allergy

鍠瑋水電

HOME > 免疫ミルクの研究

Visitor：432


心血管の健康
  1. 1. American Heart Association. (2011). Heart Disease and Stroke Statistics.
  2. 2. Department of Health, Executive Yuan, Taiwan, R.O.C. (2012). 2011 Analysis of Primary Causes of Death, unpublished statistical data.
  3. 3. Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362 (6423): 801–9.
  4. 4. Ross, R. (1999). Atherosclerosis—an inflammatory disease. N. Engl. J. Med., 340:115-126.
  5. 5. Lipid Research Clinics Program. (1984). The Lipid Research Clinics Coronary Primary Prevention Trial results: I. Reduction in the incidence of coronary heart disease. JAMA, 251:35l-64.
  6. 6. Lipid Research Clinics Program. (1984). The Lipid Research Cinics Coronary Primary Prevention Trials results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA, 251:365-74.
  7. 7. NIH Consensus Development Conference. (1985). Lowering blood cholesterol to prevent heart disease. JAMA, 253, 2080-6.
  8. 8. Witztum, J.L. (1989). Current approaches to drug therapy for the hypercholesterolemic patient. Circulation, 80:1101-14.
  9. 9. Consensus Conference. (1985). Lowering blood cholesterol to prevent heart disease. JAMA, 253, 2080-6.
  10. 10. Tynoler, H.A. (1987). Review of lipid-lowering clinical trials in relation to observational epidemiologic studies. Circulation, 76:515-22.
  11. 11. Stamler, I. & Shekelle, R. (1988). Dietary cholesterol and human coronary heart disease. Arch Pathol Lab Med., 112:1032-40.
  12. 12. European Atherosclerosis Society. (1987). Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur. Heart I, 8:77-88.
  13. 13. National Cholesterol Education Program. (1988). Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch. Intern. Med., 148:36-69.
  14. 14. New Zealand Nutrition Taskforce. (1991). Food for health: report of the Nutrition Taskforce. Wellington, NZ: Shortcut Publishing.
  15. 15. Brown, M.S. & Goldstein, I.L. (1984). How LDL receptors influence cholesterol and atherosclerosis. Sci. Am., 251:58-66.
  16. 16. Beck, L.R. (1996). Effect of S100 Milk on serum cholesterol and atherosclerosis in Watanabe rabbits. Study # RABCHOL-10. (SMBI Internal Source).
  17. 17. Ormrod, D.J. and Miller, T.E. (1992). A low molecular weight component derived from the milk of hyperimmunised cows suppresses inflammation by inhibiting neutrophil emigration. Agents Actions 37: 70-79.
  18. 18. Sharpe, S.J., Gamble, G.D. & Sharpe, D.N. (1994). Cholesterol-lowering and blood pressure effects of immune milk. American Journal of Clinical Nutrition, 59:929-934.
  19. 19. Golay, A., Ferrara J.M., Felber, J.P. & Schneider, H. (1990). Cholesterol-lowering effect of skim milk from immunized cows in hypercholesterolemic patients. American Journal of Clinical Nutrition, Vol 52, 1014-1019.
  20. 20. Stolle, R.J. & Beck, L.R. (1990). Method for treating disorders of the vascular and pulmonary systems. US Patent #4,897,265.
Immune today, healthy everyday.
Back
回上一頁置上

These statements have not been evaluated by the Food and Drug Administration.

The products mentioned here are not intended to diagnose, treat, cure or prevent any disease.